Literature DB >> 19294450

Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions.

F A Carvalho1, J P Lopes de Almeida, T Freitas-Santos, C Saldanha.   

Abstract

Circulating acetylcholine, substrate of membrane acetylcholinesterase (AChE), is known to enhance the band 3 protein degree of phosphorylation. The purpose of this study was to verify whether the band 3 phosphorylation status is associated with a G protein and whether it is an influent factor on AChE enzyme activity. From blood samples of healthy donors, erythrocyte suspensions were prepared and incubated with AChE substrate (acetylcholine) and inhibitor (velnacrine), along with protein tyrosine kinase (PTK) and tyrosine phosphatase (PTP) inhibitors. AChE activity was determined by spectrophotometry and extract samples were analyzed by western blotting using primary antibodies to different G protein subunits. Our results with phosphorylated band 3 (PTP inhibitor) show an increase in erythrocyte AChE (p < 0.0001). A dephosphorylated band 3 state (PTK inhibitor) shows a significant decrease. We identified a potential linkage of protein subunits Galpha(i1/2) and G(beta) with band 3 protein. Galpha(i1/2) and G(beta) may be linked to the band 3 C-terminal site. Galpha(i1/2) is associated with the band 3 N-terminal domain, except for the control and ACh aliquots. G(beta) is associated with both phosphorylated and dephosphorylated band 3 in the presence of velnacrine. We conclude that an erythrocyte G protein with subunits Galpha(i1/2) and G(beta) is associated with band 3. AChE depends on the degree of band 3 phosphorylation and its association with Galpha(i1/2) and G(beta).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294450     DOI: 10.1007/s00232-009-9162-8

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  37 in total

1.  Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites.

Authors:  A M Brunati; L Bordin; G Clari; P James; M Quadroni; E Baritono; L A Pinna; A Donella-Deana
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

2.  New and old integral proteins of the human erythrocyte membrane.

Authors:  Giampaolo Minetti; Annarita Ciana
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

3.  ERYTHROCYTE ACETYLCHOLINESTERASE ACTIVITY IN ABO HEMOLYTIC DISEASE OF THE NEWBORN.

Authors:  E KAPLAN; F HERZ
Journal:  Pediatrics       Date:  1964-02       Impact factor: 7.124

4.  Functional link between phosphorylation state of membrane proteins and morphological changes of human erythrocytes.

Authors:  L Bordin; G Clari; I Moro; F Dalla Vecchia; V Moret
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

5.  Identification of the major casein kinase I phosphorylation sites on erythrocyte band 3.

Authors:  C C Wang; M Tao; T Wei; P S Low
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  Biochemical, biophysical and haemorheological effects of dimethylsulphoxide on human erythrocyte calcium loading.

Authors:  N C Santos; J Figueira-Coelho; C Saldanha; J Martins-Silva
Journal:  Cell Calcium       Date:  2002-04       Impact factor: 6.817

7.  NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi.

Authors:  Jeffrey J Olearczyk; Alan H Stephenson; Andrew J Lonigro; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-08       Impact factor: 4.733

8.  Effects of choline on hemorheological properties and NO metabolism of human erythrocytes.

Authors:  Tiago Santos; Rui Mesquita; João Martins E Silva; Carlota Saldanha
Journal:  Clin Hemorheol Microcirc       Date:  2003       Impact factor: 2.375

9.  Deoxygenation affects fluorescence photobleaching recovery measurements of red cell membrane protein lateral mobility.

Authors:  J D Corbett; M R Cho; D E Golan
Journal:  Biophys J       Date:  1994-01       Impact factor: 4.033

10.  Non-neuronal cholinergic system and signal transduction pathways mediated by band 3 in red blood cells.

Authors:  Filomena A Carvalho; José Pedro Almeida; Isabel O Fernandes; Teresa Freitas-Santos; Carlota Saldanha
Journal:  Clin Hemorheol Microcirc       Date:  2008       Impact factor: 2.375

View more
  7 in total

Review 1.  Nonneuronal cholinergic system in human erythrocytes: biological role and clinical relevance.

Authors:  J P Lopes de Almeida; C Saldanha
Journal:  J Membr Biol       Date:  2010-03-30       Impact factor: 1.843

2.  Structural and compositional changes in erythrocyte membrane of obese compared to normal-weight adolescents.

Authors:  Javier S Perona; Emilio González-Jiménez; María J Aguilar-Cordero; Antonio Sureda; Francisca Barceló
Journal:  J Membr Biol       Date:  2013-10-10       Impact factor: 1.843

3.  Acetylcholinesterase conformational states influence nitric oxide mobilization in the erythrocyte.

Authors:  Pedro Teixeira; Nuno Duro; Patrícia Napoleão; Carlota Saldanha
Journal:  J Membr Biol       Date:  2015-02-05       Impact factor: 1.843

4.  Acetylcholinesterase provides new insights into red blood cell ageing in vivo and in vitro.

Authors:  Joames K Freitas Leal; Merel J W Adjobo-Hermans; Roland Brock; Giel J C G M Bosman
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

Review 5.  Application of a nitric oxide sensor in biomedicine.

Authors:  Carlota Saldanha; José Pedro Lopes de Almeida; Ana Santos Silva-Herdade
Journal:  Biosensors (Basel)       Date:  2014-02-04

Review 6.  The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications.

Authors:  Qinhong Wang; Rahima Zennadi
Journal:  Antioxidants (Basel)       Date:  2021-10-13

Review 7.  Human Erythrocyte Acetylcholinesterase in Health and Disease.

Authors:  Carlota Saldanha
Journal:  Molecules       Date:  2017-09-08       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.